Calcitriolo Teva

Calcitriolo Teva is a pharmaceutical product containing Calcitriol, a synthetic form of Vitamin D3 used to regulate calcium and phosphate levels in the body. It is primarily prescribed for patients with chronic kidney disease, osteoporosis, or calcium deficiencies related to parathyroid issues. The product is marketed as a generic equivalent to original brands like Rocaltrol.

While the specific package mentioned is commercialized in Italy by Teva Italia S.r.l., the manufacturing of Teva's vast portfolio occurs across a global network of production facilities. These are located in various regions including Israel, India, the United States, and several European countries, depending on the specific batch and dosage form (such as soft capsules or oral solutions).

Teva Pharmaceutical Industries Ltd., the ultimate owner, is a multinational pharmaceutical giant headquartered in Tel Aviv, Israel. Founded in 1901, it has grown through significant acquisitions to become the world's largest generic drug manufacturer. Today, it is a publicly traded company on both the New York (NYSE) and Tel Aviv (TASE) stock exchanges, with its ownership primarily held by major global institutional investors.